DK0896583T3 - Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder - Google Patents

Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder

Info

Publication number
DK0896583T3
DK0896583T3 DK97920610T DK97920610T DK0896583T3 DK 0896583 T3 DK0896583 T3 DK 0896583T3 DK 97920610 T DK97920610 T DK 97920610T DK 97920610 T DK97920610 T DK 97920610T DK 0896583 T3 DK0896583 T3 DK 0896583T3
Authority
DK
Denmark
Prior art keywords
ospc
lys
seq
acid residues
disclosed
Prior art date
Application number
DK97920610T
Other languages
Danish (da)
English (en)
Inventor
Marianne Jartved Mathiesen
Michael Theisen
Arne Holm
Soren Ostergaard
Original Assignee
Dako As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dako As filed Critical Dako As
Application granted granted Critical
Publication of DK0896583T3 publication Critical patent/DK0896583T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK97920610T 1996-05-02 1997-05-02 Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder DK0896583T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK52696 1996-05-02
PCT/DK1997/000203 WO1997042221A1 (en) 1996-05-02 1997-05-02 Novel osp-c derived peptide fragments

Publications (1)

Publication Number Publication Date
DK0896583T3 true DK0896583T3 (da) 2003-05-26

Family

ID=8094548

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97920610T DK0896583T3 (da) 1996-05-02 1997-05-02 Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder

Country Status (6)

Country Link
EP (1) EP0896583B1 (de)
AT (1) ATE232212T1 (de)
CA (1) CA2253374C (de)
DE (2) DE896583T1 (de)
DK (1) DK0896583T3 (de)
WO (1) WO1997042221A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008625B2 (en) 1993-11-01 2006-03-07 Research Foundation Of The State University Of New York Recombinant constructs of Borrelia burgdorferi
EP0949508A1 (de) * 1998-04-08 1999-10-13 Dako A/S Verfahren, Antigen-Komplex und Satz zur Diagnose Lyme-Borreliose
ATE386805T1 (de) 1998-07-31 2008-03-15 Gundersen Lutheran Medical Fou Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff
AU6078399A (en) * 1998-09-29 2000-04-17 Arne Holm Ligand presenting assembly (lpa), method of preparation and uses thereof
AU5751000A (en) 1999-06-18 2001-01-09 Brook Biotechnologies, Inc. Groups of borrelia burgdorferi and borrelia afzelii that cause lyme disease in humans
WO2002016421A2 (en) 2000-08-18 2002-02-28 Research Foundation Of The State University Of New York Altered ospa of borrelia burgdorferi
US7045134B2 (en) 2000-10-24 2006-05-16 University Of Medicine And Dentistry Of New Jersey Borellia burgdorferi epitope peptides
US6913936B2 (en) 2000-10-24 2005-07-05 University Of Medicine And Dentistry Of New Jersey Immunological test kit comprising an immunologically invisible peg copolymer conjugated to one or more immunologically reactive substances
US20030040127A1 (en) * 2000-10-24 2003-02-27 Bo Qiu Multiple epitopes connected by a carrier
WO2002090961A2 (en) 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7262019B2 (en) 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
WO2008116468A2 (en) 2007-03-26 2008-10-02 Dako Denmark A/S Mhc peptide complexes and uses thereof in infectious diseases
EP3023436A1 (de) 2007-07-03 2016-05-25 Dako Denmark A/S Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
EP2197908A2 (de) 2007-09-27 2010-06-23 Dako Denmark A/S Mhc-multimere in tuberkulose-diagnostika, -impfstoff und therapeutika
US10968269B1 (en) 2008-02-28 2021-04-06 Agilent Technologies, Inc. MHC multimers in borrelia diagnostics and disease
WO2010009735A2 (en) 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
GB0817244D0 (en) 2008-09-20 2008-10-29 Univ Cardiff Use of a protein kinase inhibitor to detect immune cells, such as T cells
US10369204B2 (en) 2008-10-02 2019-08-06 Dako Denmark A/S Molecular vaccines for infectious disease
US11992518B2 (en) 2008-10-02 2024-05-28 Agilent Technologies, Inc. Molecular vaccines for infectious disease
PL2199303T3 (pl) 2008-12-12 2013-11-29 Euroimmun Medizinische Labordiagnostika Ag Polipeptydy i sposoby swoistego wykrywania przeciwciał u pacjentów z zakażeniem krętkami Borrelia
BR112013007329A2 (pt) * 2010-09-27 2016-07-19 Univ Cornell método para diagnostificar o estado de doença de lyme em um mamífero, e, composição

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054296A (en) * 1988-10-24 2000-04-25 Symbicom Ab 66 kDa antigen from Borrelia
DE69408135T2 (de) * 1993-04-29 1998-06-10 Immuno Ag Ospc-antigen-impfstoffe immunogene zusammensetzung zur vorbeugung und behandlung von lyme-krankheit und rekombinante verfahren zur herstellung von derartige antigene

Also Published As

Publication number Publication date
DE69718903T2 (de) 2003-12-04
DE69718903D1 (de) 2003-03-13
EP0896583A1 (de) 1999-02-17
CA2253374A1 (en) 1997-11-13
ATE232212T1 (de) 2003-02-15
WO1997042221A1 (en) 1997-11-13
DE896583T1 (de) 2000-03-09
CA2253374C (en) 2004-07-20
EP0896583B1 (de) 2003-02-05

Similar Documents

Publication Publication Date Title
DK0896583T3 (da) Anvendelse af peptidfragmenter fra OspC til diagnostiske metoder
Probert et al. Identification and characterization of a surface-exposed, 66-kilodalton protein from Borrelia burgdorferi
DE60332645D1 (de) Ii-key/antigene epitop-hybrid-peptid-vakzine
NO329875B1 (no) Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
DK0662827T3 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
CA2299677A1 (en) Preparation and use of recombinant influenza a virus m2 constructs and vaccines
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
EP2311952A3 (de) Antikörper gegen MART-1 Protein oder Fragmenten davon
HUP0001930A2 (hu) Módosított TNFalfa-molekulák, ilyen módosított TNFalfa-molekulákat kódoló DNS, valamint ilyen módosított TNFalfa-molekulát és DNS-t tartalmazó vakcinák
WO1998004702A3 (en) Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use
CA2175567A1 (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
DE69233311D1 (de) Weidelgraspollen-allergen
ATE159546T1 (de) Allergene aus roggenspreupollen
FR2828405B1 (fr) Vaccin anti-coronavirus
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
NO20011263L (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
Yang et al. Determination of the molecular mass of apolipoprotein B-100 A chemical approach
ZA907944B (en) Hiv related peptides
GEN Maria Kehl and Agnes Henschen
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
Kausler et al. Analysis of peptides of human seminal plasma by mass spectrometry
NZ311874A (en) Recombinant and/or pure preparations of H. pylori polypeptides and nucleic acids which are useful for diagnostics and vaccines
MX9709846A (es) Secuencias de acidos nucleico y aminoacidos relacionados con el helicobacter pylori para procedimientos de diagnostico y terapeuticos.
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods